Skip to content

Meet TCG
Our Portfolio
In the News
Join our Ecosystem

Contact Us
Investor Login

Contact Us
Investor Login

April 26, 2022

Dr. Sarah Hymowitz Promoted from Venture Partner to Partner

/ TCG News / By Karina Tin

The Column Group announces the promotion of Dr. Sarah Hymowitz from Venture Partner to Partner. Dr. Hymowitz has been with TCG since 2021.

Post navigation

← Previous Post

In The News

Featured news from our team and portfolio

Thumbnail for The Column Group Raises Over $400 Million For Its New Fund, TCG Labs-Soleil

The Column Group Raises Over $400 Million For Its New Fund, TCG Labs-Soleil

The Column Group launches a novel ‘venture-biotech’ model, creating an integrated ecosystem to exclusively fund, discover, and develop single-asset biologic therapies.

Portfolio News

03.10.25

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

03.06.25

RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

03.03.25

Tenaya Therapeutics Announces Pricing of Public Offering

02.26.25

Eikon Therapeutics Secures $350.7 Million Series D to Advance Clinical-Stage Programs and Future Pipeline

02.25.25

ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones

02.24.25

NGM Bio Announces First Participant Dosed in EMERALD Phase 2 Clinical Study of NGM120 for the Treatment of Hyperemesis Gravidarum (HG) in Pregnant Patients

Meet TCG
Our Portfolio
In The News
Join Our Ecosystem
Contact Us
Investor Login

Meet TCG
Join Our Ecosystem
Our Portfolio
Contact Us
In The News
Investor Login

Copyright © 2025. The Column Group

Privacy Policy
Terms of Use

Scroll to Top